LUCAT1 and hepatocellular carcinoma: To further explore the clinical significance of the aberrant expression of LUCAT1 in HCC, according to the bimodal expression pattern of LUCAT1 in HCC patients (Figure S1A), we separated all the HCC patients into two groups: LUCAT1‐high expression group and LUCAT1‐low expression group based on the median value of LUCAT1.